Cargando…
PReS-FINAL-2171: Consensus: what agent to use when first-line vasodilators fail in Raynaud's phenomenon or digital ulcers secondary to rheumatic diseases in children?
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4042594/ http://dx.doi.org/10.1186/1546-0096-11-S2-P183 |
_version_ | 1782318838582345728 |
---|---|
author | Katsicas, M Gonzalez, M Russo, R |
author_facet | Katsicas, M Gonzalez, M Russo, R |
author_sort | Katsicas, M |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-4042594 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2013 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-40425942014-06-17 PReS-FINAL-2171: Consensus: what agent to use when first-line vasodilators fail in Raynaud's phenomenon or digital ulcers secondary to rheumatic diseases in children? Katsicas, M Gonzalez, M Russo, R Pediatr Rheumatol Online J Poster Presentation BioMed Central 2013-12-05 /pmc/articles/PMC4042594/ http://dx.doi.org/10.1186/1546-0096-11-S2-P183 Text en Copyright © 2013 Katsicas et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Poster Presentation Katsicas, M Gonzalez, M Russo, R PReS-FINAL-2171: Consensus: what agent to use when first-line vasodilators fail in Raynaud's phenomenon or digital ulcers secondary to rheumatic diseases in children? |
title | PReS-FINAL-2171: Consensus: what agent to use when first-line vasodilators fail in Raynaud's phenomenon or digital ulcers secondary to rheumatic diseases in children? |
title_full | PReS-FINAL-2171: Consensus: what agent to use when first-line vasodilators fail in Raynaud's phenomenon or digital ulcers secondary to rheumatic diseases in children? |
title_fullStr | PReS-FINAL-2171: Consensus: what agent to use when first-line vasodilators fail in Raynaud's phenomenon or digital ulcers secondary to rheumatic diseases in children? |
title_full_unstemmed | PReS-FINAL-2171: Consensus: what agent to use when first-line vasodilators fail in Raynaud's phenomenon or digital ulcers secondary to rheumatic diseases in children? |
title_short | PReS-FINAL-2171: Consensus: what agent to use when first-line vasodilators fail in Raynaud's phenomenon or digital ulcers secondary to rheumatic diseases in children? |
title_sort | pres-final-2171: consensus: what agent to use when first-line vasodilators fail in raynaud's phenomenon or digital ulcers secondary to rheumatic diseases in children? |
topic | Poster Presentation |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4042594/ http://dx.doi.org/10.1186/1546-0096-11-S2-P183 |
work_keys_str_mv | AT katsicasm presfinal2171consensuswhatagenttousewhenfirstlinevasodilatorsfailinraynaudsphenomenonordigitalulcerssecondarytorheumaticdiseasesinchildren AT gonzalezm presfinal2171consensuswhatagenttousewhenfirstlinevasodilatorsfailinraynaudsphenomenonordigitalulcerssecondarytorheumaticdiseasesinchildren AT russor presfinal2171consensuswhatagenttousewhenfirstlinevasodilatorsfailinraynaudsphenomenonordigitalulcerssecondarytorheumaticdiseasesinchildren |